Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases

Por Menzella, Francesco, Lusuardi, Mirco, Galeone, Carla, Taddei, Sofia, Zucchi, Luigi
Publicado no J Asthma Allergy (2015)

Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential

Por Menzella, Francesco, Lusuardi, Mirco, Galeone, Carla, Taddei, Sofia, Facciolongo, Nicola, Zucchi, Luigi
Publicado no Ther Adv Chronic Dis (2016)